dc.contributor.author | Adetayo, O | |
dc.contributor.author | Omoni, GM | |
dc.contributor.author | Aluko, Rotimi | |
dc.date.accessioned | 2013-06-29T07:55:52Z | |
dc.date.available | 2013-06-29T07:55:52Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Volume 16, Issue 8, August 2005, Pages 344–350 | en |
dc.identifier.uri | http://www.sciencedirect.com/science/article/pii/S0924224405000373 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/42131 | |
dc.description.abstract | Considerable evidence from several epidemiological studies suggests that lycopene has anti-carcinogenic and anti-atherogenic potential, the effects of which have been attributed primarily to its antioxidant properties (lycopene quenches singlet oxygen almost twice as well as β-carotene does). These epidemiological leads have stimulated a number of animal model and cell culture studies designed to test this hypothesis and to establish its beneficial effects. This review will focus on the anti-atherogenic and anti-carcinogenic effects of lycopene, and point out areas for future research to further elucidate mechanisms whereby this compound may reduce cancer and cardiovascular disease risk. | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Volume16; | |
dc.title | The anti-carcinogenic and anti-atherogenic effects of lycopene: a review | en |
dc.type | Article | en |
local.publisher | School of Nursing | en |